505
Views
0
CrossRef citations to date
0
Altmetric
Corrigenda

Corrigendum

This article refers to:
Comparative hazard identification of nano- and micro-sized cerium oxide particles based on 28-day inhalation studies in rats

GOSENS, I., MATHIJSSEN, L., BOKKERS, B., MUIJSER, H., and CASSEE, F. (2013) Comparative hazard identification of nano- and micro-sized cerium oxide particles- based on 28-day inhalation studies in rats. Nanotoxicology, http://dx.doi.org/10.3109/17435390.2013.815814

When the above article was first published online, the two time points for cell analyses in the broncho alveolar lavage fluid are incorrectly described in figure legends 1,2 and 3 as being after 28 days and after a recovery period of 60 days. The correct timing of the cell analyses is 1 day after the final exposure to cerium oxide and after a recovery time of 28 days, as described in the materials and methods section. The figure legends should read:

Figure 1. Cell analyses of BALF in male and female rats after inhalation of NM-213 CeO2 (micro-sized), the day after the final exposure and after a recovery period of 28 days. (A) Total cell number, (B) number of macrophages, (C) number of neutrophils and (D) number of lymphocytes are shown; *p < 0.05 is compared to the respective control group.

Figure 2. Cell analyses of BALF in male and female rats after inhalation of NM-212 CeO2 (nanosized), the day after the final exposure and after a recovery period of 28 days. (A) Total number of cells, (B) number of macrophages, (C) number of neutrophils and (D) number of lymphocytes are shown; *p < 0.05 is compared to the respective control group.

Figure 3. Cell analyses of BALF in male and female rats after inhalation of NM-211 CeO2 (nanosized), the day after the final exposure and after a recovery period of 28 days. (A) Total number of cells, (B) number of macrophages, (C) number of neutrophils and (D) number of lymphocytes are shown; *p < 0.05 is compared to the respective control group.

The author apologises for this error.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.